Journal ArticleJ Clin Med · November 24, 2021
The impact of HLA matching on graft survival has been well characterized in renal transplantation, with a higher degree of matching associated with superior graft survival. Additionally, living donor grafts are known to confer superior survival compared to ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · April 2014
BACKGROUND: Even after negative sentinel lymph node biopsy (SLNB) for primary melanoma, patients who develop in-transit (IT) melanoma or local recurrences (LR) can have subclinical regional lymph node involvement. STUDY DESIGN: A prospective database ident ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · August 2011
BACKGROUND: Hyperthermic isolated limb perfusion (HILP) and isolated limb infusion (ILI) are used to manage advanced extremity melanoma, but no consensus exists as to which treatment is preferable and how to monitor patients post-treatment. STUDY DESIGN: U ...
Full textLink to itemCite
Journal ArticleAm Surg · July 2011
A number of general surgery training programs offer a dedicated research experience during the training period. There is much debate over the importance of these experiences with the added constraints placed on training surgeons including length of trainin ...
Link to itemCite
Journal ArticleJ Pediatr Surg · August 2009
PURPOSE: Differentiating pigmented skin lesions from malignant melanoma in the pediatric population has been a challenge. Despite guidelines describing clinical features and histopathologic criteria to distinguish these lesions, misdiagnoses still occur. W ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2009
BACKGROUND: Isolated limb infusion (ILI) is a minimally invasive approach for treating in-transit extremity melanoma, with only two US single-center studies reported. Establishing response and toxicity to ILI as compared with hyperthermic isolated limb per ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2008
BACKGROUND: Isolated limb infusion (ILI) is a recently described minimally invasive technique developed in Australia for delivering regional chemotherapy. This study examined the efficacy and toxicity of ILI, compared to hyperthermic isolated limb perfusio ...
Full textLink to itemCite
Journal ArticleBlood · December 15, 2007
The process of dendritic cell (DC) maturation, critical for effective DC-based immunotherapy, also alters the proteasome such that peptides presented in the context of HLA class I are generated not by the constitutive proteasome, but by the immunoproteasom ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · January 2007
OBJECTIVES: The outcomes of patients with metastatic melanoma are poor. Although prognostic models have been developed to predict the occurrence of pulmonary metastasis from cutaneous melanoma, few data exist to define the outcomes of these patients once m ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · September 1, 2006
BACKGROUND AND OBJECTIVES: To analyze the Kraske procedure as an approach to mid-rectal disease. METHODS: Twenty-two patients underwent a Kraske procedure at either Duke University Medical Center, the Durham Veterans Administration Medical Center, or the D ...
Full textLink to itemCite
Journal ArticleAnn Plast Surg · July 2006
BACKGROUND: In 2005, it is now estimated that one in 62 Americans have a lifetime risk of developing invasive melanoma. Melanoma of the ear accounts for 1% of all cases of melanoma and 14.5% of all head and neck melanomas. With this increase in incidence, ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · May 2006
BACKGROUND: Desmoplastic melanoma (DM) has been associated with higher local recurrence rates than other types of cutaneous melanoma. Current controversies regarding locoregional treatment strategies warrant further investigation. METHODS: Retrospective re ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 2006
BACKGROUND: The incidence of carcinoma of the gastroesophageal junction (GEJ) is rapidly increasing, and the prognosis remains poor. We examined outcomes in patients who received neoadjuvant chemoradiation for GEJ tumors to identify factors that predict di ...
Full textLink to itemCite
Journal ArticleJ Invest Dermatol · January 2006
Stem cells play a critical role in normal tissue maintenance, and mutations in these stem cells may give rise to cancer. We hypothesize that melanoma develops from a mutated stem cell and therefore residual stem cell characteristics should be able to be id ...
Full textLink to itemCite
Journal ArticleArch Surg · November 2005
HYPOTHESIS: Analysis of multiple clinical and pathological factors in patients undergoing therapeutic hyperthermic isolated limb perfusion for extremity melanoma can identify variables with prognostic significance. DESIGN: Retrospective review of a prospec ...
Full textLink to itemCite
Journal ArticleAnn Plast Surg · January 2005
Cutaneous melanoma remains an ongoing public health threat, and the cornerstone of management continues to be early diagnosis and treatment. Unfortunately, primary melanomas may have atypical presentations, making early diagnosis difficult and causing sign ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · March 1, 2004
PURPOSE: Eniluracil, an effective inactivator of dihydropyrimidine dehydrogenase, allows for oral dosing of 5-fluorouracil (5-FU), which avoids the morbidity of continuous infusion 5-FU. We addressed the safety of oral eniluracil and 5-FU combined with pre ...
Full textLink to itemCite
Journal ArticleAnn Surg · October 2003
OBJECTIVE: To guide treatment and clinical follow-up by defining the natural history of thin melanomas and identifying negative prognostic characteristics that may delineate high-risk patients. SUMMARY BACKGROUND DATA: In following > 10,000 patients with c ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · February 2003
Featured Publication
The rare finding of heterotopic ossification in a case of primary rectal adenocarcinoma is described along with a review of the literature. Immunohistochemistry for a bone morphogenic protein (BMP-2) and fibroblast growth factor (FGF-2), both of which indu ...
Full textLink to itemCite
Journal ArticleCancer · September 15, 2002
Featured Publication
BACKGROUND: The clinical course of cutaneous melanoma is associated with pathologic and clinical factors, such as thickness, ulceration, and location of tumor and gender of the patient. The authors used a parametric survival model that incorporated a cured ...
Full textLink to itemCite
Journal ArticleMol Biol Rep · September 2002
ADAM family plays important roles in neurogenesis. The cytoplasmic tail of ADAM19 (ADAM19-CT) contains 193 residues. The presence of two putative SH3 ligand-binding sites suggests potential interactions with cytosolic proteins, which could be possibly link ...
Full textLink to itemCite
Journal ArticleNature · June 27, 2002
Featured Publication
Cancers arise owing to the accumulation of mutations in critical genes that alter normal programmes of cell proliferation, differentiation and death. As the first stage of a systematic genome-wide screen for these genes, we have prioritized for analysis si ...
Full textLink to itemCite
Journal ArticleAnn Surg · June 2002
Featured Publication
OBJECTIVE: To examine the long-term outcomes of patients with melanoma metastatic to regional lymph nodes. SUMMARY BACKGROUND DATA: Regional lymph node metastasis is a major determinant of outcome for patients with melanoma, and the presence of regional ly ...
Full textLink to itemCite
Journal ArticleJ Gastrointest Surg · 2002
Featured Publication
Secondary peptic ulcer surgery is uncommon given the success of a wide variety of medical therapies, plus the good outcome expected after primary peptic ulcer surgery. Early reports of secondary peptic ulcer surgery in the 1950s and 1960s suggested good lo ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2001
BACKGROUND: Up to 30% of patients with locally advanced rectal cancer have a complete clinical or pathologic response to neoadjuvant chemoradiation. This study analyzes complete clinical and pathologic responders among a large group of rectal cancer patien ...
Full textLink to itemCite
Journal ArticleJ Cutan Pathol · October 2001
BACKGROUND: Malignant melanoma is notorious for the wide range of histologic patterns it can assume, among the least frequent of which is chondroid melamona. METHODS: Two cases of primary chondroid melanoma of the distal lower extremity were studied. Tissu ...
Full textLink to itemCite
Journal ArticleCell Immunol · June 15, 2001
Recognition of melanoma antigens by HLA class-II-restricted CD4(+) T lymphocytes has been investigated. Two cytotoxic CD4(+) T cell lines were established by stimulating PBLs from a melanoma patient with either parental or IFN-gamma-transduced autologous t ...
Full textLink to itemCite
Journal ArticleAnn Surg · June 2001
OBJECTIVE: To evaluate the accuracy of percutaneous, image-guided core-needle breast biopsy (CNBx) and to compare the surgical management of patients with breast cancer diagnosed by CNBx with patients diagnosed by surgical needle-localization biopsy (SNLBx ...
Full textLink to itemCite
Journal ArticleAnn Surg · June 2001
OBJECTIVE: To examine clinical outcomes in patients receiving neoadjuvant chemoradiation for locally advanced rectal adenocarcinoma. SUMMARY BACKGROUND DATA: Preoperative radiation therapy, either alone or in combination with 5-fluorouracil-based chemother ...
Full textLink to itemCite
Journal ArticleCancer · March 1, 2001
BACKGROUND: There is good prognostic correlation for the two microstaging systems, Breslow depth and Clark level, commonly used to stage melanomas. Many investigators have reported that Breslow depth is the superior microstaging method. Although Clark leve ...
Link to itemCite
Journal ArticleAm J Clin Pathol · February 2001
Although the Breslow thickness provides the most important histologic information for prognosis in cutaneous melanoma, controversies and uncertainty remain about how best to use thickness. It is unclear whether cut points should be used, or, if they are us ...
Full textLink to itemCite
Journal ArticleCancer J · 2001
PURPOSE: Sentinel lymph node mapping using radiolabeled tracer and blue dye is widely accepted and applied for staging melanoma. Common practice involves injection of radiolabeled tracer on the morning of surgery. However, optimal timing of radiolabeled co ...
Link to itemCite
Journal ArticleAm J Clin Pathol · December 2000
Although many statistical models have been developed to predict survival in cutaneous melanoma, few predict the end point of regional lymph node metastasis shortly after the diagnosis of melanoma. We used routine clinical and histologic data from 573 patie ...
Full textLink to itemCite
Journal ArticleAnn Surg · October 2000
OBJECTIVE: To describe a large series of patients with carcinoid tumors in terms of presenting symptoms, hormonal data, stage at diagnosis, pathologic features, and survival. SUMMARY BACKGROUND DATA: Published series have described significant prognostic f ...
Full textLink to itemCite
Journal ArticleClin Orthop Relat Res · September 2000
From 1970 to 1996, 93 patients received diagnoses of subungual melanoma. Followup data were complete on all patients and reviewed with a median duration of followup of 5.2 years. This study identifies significant clinicopathologic variables that affect sur ...
Link to itemCite
Journal ArticleCancer · September 1, 2000
BACKGROUND: Several recent studies have demonstrated the low yield of anatomically based computed tomography scans in evaluating Stage III (American Joint Committee on Cancer) patients with malignant melanoma. The purpose of this study was to investigate t ...
Link to itemCite
Journal ArticleCancer · September 1, 2000
BACKGROUND: There have been few studies of depression in nonsmall cell lung carcinoma (NSCLC) patients after successful treatment. The purpose of the study was to clarify the prevalence and the correlated factors of depression after surgery. METHODS: A str ...
Full textLink to itemCite
Journal ArticleJ Immunol · April 15, 2000
To investigate the ability of human dendritic cells (DC) to process and present multiple epitopes from the gp100 melanoma tumor-associated Ags (TAA), DC from melanoma patients expressing HLA-A2 and HLA-A3 were pulsed with gp100-derived peptides G9154, G920 ...
Full textLink to itemCite
Journal ArticleCancer · March 1, 2000
BACKGROUND: Local recurrence of melanoma is associated with a grave prognosis. However, the characteristics and the mode of disease progression for patients with local recurrence have not been adequately addressed in the literature. METHODS: A retrospectiv ...
Full textLink to itemCite
Journal ArticleInt J Cancer · November 12, 1999
Dendritic cells (DCs) are potent inducers of cytotoxic T lymphocytes (CTLs) when pulsed with an antigenic peptide or tumor lysate. In this report, we have used liposome-mediated gene transfer to examine the ability of plasmid DNA encoding the human melanom ...
Full textLink to itemCite
Journal ArticleSurgery · August 1999
BACKGROUND: Sentinel lymph node (SLN) mapping is an effective technique for staging patients with melanoma. In an attempt to avoid reinjection of radiolabeled colloid and facilitate SLN mapping at the time of surgery, we examined whether residual radioacti ...
Link to itemCite
Journal ArticleJ Surg Oncol · May 1999
BACKGROUND AND OBJECTIVES: Vaccination with cytokine gene-modified tumor cells augments the immune response against established tumors and protects against tumor challenges. In this study, we investigated the vaccine potential of GM-CSF-transduced MCA106 f ...
Full textLink to itemCite
Journal ArticleBioDrugs · April 1999
Cancer remains one of the most important public health concerns facing us today. Despite recent therapeutic developments, conventional therapies have provided only limited success in the management of patients with advanced disease. The recent discovery of ...
Full textLink to itemCite
Journal ArticleGene Ther · February 1999
Genetic modification of tumor cells with the gene for the B7.1 or with the genes for cytokines results in increased tumor cell immunogenicity. In the work reported here, immunization of naive animals with either B7.1 or gamma-IFN gene-modified MCA106 tumor ...
Full textLink to itemCite
Journal ArticleCancer · January 1, 1999
BACKGROUND: Both primary and metastatic melanoma of the gallbladder are rare. In cases involving isolated tumors of the gallbladder, there continues to be controversy regarding the establishment of primary status. Despite appropriate therapy, the diagnosis ...
Link to itemCite
Journal ArticleAnn Surg Oncol · December 1998
BACKGROUND: Melanomas arising from the mucous membranes lining the respiratory, digestive, and genitourinary tracts are rare. Women are more commonly affected than are men, mainly because there is no male counterpart for vulvovaginal lesions. The mainstay ...
Full textLink to itemCite
Journal ArticleDiagn Cytopathol · October 1998
BACKGROUND: The optimal format for reporting results of breast fine-needle aspiration cytology is controversial, with some experts favoring a five-category system and others recommending a four-category format. METHODS: A survey of 200 surgeons was perform ...
Full textLink to itemCite
Journal ArticleSurgery · July 1998
BACKGROUND: Mucosal melanoma of the female genitalia is a rare neoplasm. Only nine reports reviewing more than 40 patients have been published on this subject in the past 30 years. These lesions arise from melanocytes, which can be found within the mucosa ...
Link to itemCite
Journal ArticleJ Surg Oncol · June 1998
BACKGROUND AND OBJECTIVES: Dendritic cells (DC) pulsed in vitro with a variety of antigens have proved effective in producing specific antitumor effects in vivo. Experimental evidence from other laboratories has confirmed that shared antigens can be encoun ...
Full textLink to itemCite
Journal ArticleCell Immunol · May 25, 1998
Dendritic cells (DCs) pulsed with unfractionated tumor cell lysates or defined tumor peptides provide potent vaccines which elicit strong antitumor immunity. In this study, we generated DCs from the 2-h adherent progenitor cells obtained from the periphera ...
Full textLink to itemCite
Journal ArticleCell Immunol · April 10, 1998
Dendritic cells (DC) are specialized antigen-presenting cells that can activate naive and mature T-cells, induce cellular immunity, and stimulate strong antitumor reactions in vivo. This study was undertaken to examine the function of DC vaccines in suppre ...
Full textLink to itemCite
Journal ArticleJ Neurosurg · January 1998
UNLABELLED: Brain metastases are a common and devastating complication in patients with malignant melanoma. Therapeutic options for these patients are limited, and the prognosis is usually poor. OBJECT: A retrospective review of 6953 patients with melanoma ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · November 1997
A 48-year-old woman presented with a 6-month history of dysphagia, often associated with retrosternal chest pain. Upper endoscopy revealed an unusual pigmented lesion within the middle portion of the esophagus, and multiple biopsies were obtained. The hist ...
Full textLink to itemCite
Journal ArticleCancer · August 1, 1997
BACKGROUND: Tumor cells transduced with cytokine genes provide immunogenic vaccines for cancer immunotherapy. METHODS: A Phase I clinical trial was conducted for the specific active immunization of melanoma patients with interferon-gamma (IFN-gamma) gene-m ...
Full textLink to itemCite
Journal ArticleCell Immunol · July 10, 1997
Dendritic cells (DC) are highly efficient antigen-presenting cells able to capture, process, and present antigens to naive and primed T-cells. In this study, we have investigated the ability of DC, derived from murine bone marrow and pulsed with tumor cell ...
Full textLink to itemCite
Journal ArticleCancer Res · April 15, 1997
Expression of B7.1 costimulatory molecules on tumor cells has been shown to elicit antitumor immunity in mice. In the present study, we have developed a human B7.1 retroviral vector system to effectively transduce human melanoma cell lines and investigated ...
Link to itemCite
Journal ArticleCancer Gene Ther · 1997
This study was undertaken to investigate the effectiveness of interleukin-2 (IL-2) and gamma interferon (gammaIFN)-modified B16 melanoma cells in the immunotherapy of established melanoma pulmonary metastases. The genes for IL-2 and gammaIFN were introduce ...
Link to itemCite
Journal ArticleCell Immunol · August 25, 1996
The in vitro cytotoxic response to human melanoma is characterized by CD3+ CD8+ T-cells which recognize shared peptide antigens presented in the context of HLA class-I-encoded gene products. We report here studies of a CD3+, CD4+, CD8-, HLA-A2-restricted, ...
Full textLink to itemCite
Journal ArticleCell Immunol · August 1, 1996
Recent studies have shown that tumor cells transduced with interleukin-2 (IL-2) or interferon-gamma (IFN-gamma) genes stimulated a potent and specific antitumor immunity in experimental animals. For use as a human vaccine, tumor cells must be inactivated b ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · May 1996
BACKGROUND: Recent studies have demonstrated the usefulness of gene-modified tumor cells for immunotherapy. Using the tumorigenic murine fibrosarcoma, MCA 106, we investigated the effects of localized interferon-gamma (IFNg) secretion on tumorigenicity and ...
Full textLink to itemCite
Journal ArticleSurg Oncol · 1996
Specific active immunization with tumour cells and IL-1beta or IL-2 was examined in a murine model. Mice were treated with irradiated B16 melanoma, IL-1beta or IL-2 only, or with B16 plus cytokines prior to i.v. challenge with viable B16. Lung metastases w ...
Full textLink to itemCite
Journal ArticleClinical Consultations in Obstetrics and Gynecology · December 1, 1995
J.P. is a 35-year-old white female who presented in December 1988 with an irregular pigmented lesion on her right lower thigh and a palpable node in her right groin. Biopsy of the lesion showed an ulcerated, Clark Level 4. 2.7 mm malignant melanoma [Fig 1) ...
Cite
Journal ArticleCancer Control · October 1995
The incidence of melanoma in the United States is increasing at a faster rate than that of any other cancer. The prognosis for metastatic disease is poor, and more effective treatments for disseminated disease are needed. Since melanoma is one of the more ...
Full textLink to itemCite
Journal ArticleSpine (Phila Pa 1976) · October 1, 1995
STUDY DESIGN: One-hundred-fourteen patients with metastatic melanoma of the spine were retrospectively reviewed. OBJECTIVE: The goal was to define the demographics, risk factors, and prognosis for this population. SUMMARY OF BACKGROUND DATA: The incidence ...
Full textLink to itemCite
Journal ArticleAnn Surg · June 1995
OBJECTIVE: In this study, the impact of preoperative chemotherapy and radiation on the histopathology of a subgroup of patients with rectal adenocarcinoma was examined. As well, survival, disease-free survival and pelvic recurrence rates were examined, and ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 1994
OBJECTIVE: The aim of this study was to determine the order of melanoma nodal metastases. SUMMARY BACKGROUND DATA: Most solid tumors are thought to demonstrate a random nodal metastatic pattern. The incidence of skip nodal metastases precluded the use of s ...
Full textLink to itemCite
Journal ArticleCell Immunol · November 1994
Human melanoma tumor cells were genetically modified in vitro by transferring the interleukin-2 (IL-2) gene via a retroviral vector into established or fresh tumor cells. In addition, human melanoma cells were transduced in vivo by the direct injection of ...
Full textLink to itemCite
Journal ArticleCancer Gene Ther · September 1994
Human tumor cells transduced with the gamma interferon (gamma IFN) gene are currently used in specific active immunotherapy protocols to enhance the antitumor immune responses of cancer patients. This in vitro study was undertaken to examine the initial ev ...
Link to itemCite
Journal ArticleAnn Surg Oncol · July 1994
BACKGROUND: Cutaneous melanoma is an uncommon malignancy in children and for this reason, there is little information available regarding the timing and patterns of recurrence in children with this disease. This study reviews the experience at a single ins ...
Full textLink to itemCite
Journal ArticleJ Bone Joint Surg Am · June 1994
We performed a prospective study of the results of treatment of primary cutaneous melanoma of the foot in 282 patients to determine if there were any factors that could predict survival. These patients were part of a group of 1018 patients who had primary ...
Full textLink to itemCite
Journal ArticleArch Surg · March 1994
OBJECTIVE: To evaluate the effects of gender on prognostic outcome of patients with melanoma. DESIGN: Retrospective cohort study, including 20 years of follow-up. SETTING: Duke University Melanoma Clinic, Durham, NC, a referral center for patients with mel ...
Full textLink to itemCite
Journal ArticleAnn Surg · February 1994
OBJECTIVE: The purpose of this study was to evaluate a large number of patients with cutaneous melanoma who had or who were at risk for lymph node metastases to contribute to the understanding of the behavior of and appropriate management of draining nodes ...
Full textLink to itemCite
Journal ArticleCancer Res · January 15, 1994
Topoisomerase I has been identified as an intracellular target of camptothecin, a plant alkaloid with anticancer activity. Various lines of evidence suggest that the sensitivity of cells to this drug is directly related to the topoisomerase I content. In h ...
Link to itemCite
Journal ArticleMelanoma Res · December 1993
An IgM human monoclonal antibody (human MAb) was generated by fusing lymph node cells isolated from a surgical specimen of malignant melanoma with the heteromyeloma cell line SHMD-33. The antibody, designated 7c11.e8, reacted with surface antigens on human ...
Full textLink to itemCite
Journal ArticleCancer · August 15, 1993
BACKGROUND: Previously, nonparametric or semiparametric methods have been used to determine the relationship of various prognostic covariates with survival of skin cancer. Unfortunately, these methods do not readily distinguish between factors that modulat ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · July 7, 1993
BACKGROUND: Chemotherapy adjuvant to surgery in metastatic melanoma has been evaluated in only a few prospective randomized trials. In the treatment of metastatic melanoma, dacarbazine has response rates of 15%-25% and in several studies, when combined wit ...
Full textLink to itemCite
Journal ArticleLaryngoscope · May 1993
Historically, lentigo maligna melanoma has been considered a "favorable" histological type of melanoma, and treatment by wide local excision was considered curative. A retrospective multivariate analysis of 143 head and neck patients with stage I lentigo m ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 1993
Since 1985, 229 cases of carcinoma of the esophagus have been considered for entry into a protocol with the use of preoperative chemotherapy and radiation therapy followed by surgical intervention as the primary element of treatment. One hundred sixty-five ...
Link to itemCite
Journal ArticleSurgery · March 1993
To identify patients with melanoma at risk for a second primary lesion and to assess the prognostic relevance of multiple primary lesions, 7816 patients treated for malignant melanoma have been reviewed. Two to nine primary lesions were identified in 283 p ...
Link to itemCite
Journal ArticleSemin Surg Oncol · 1993
Americans are clearly losing the battle against malignant melanoma. In 1930, it was estimated that one in 1,500 people would develop melanoma sometime during their lifetimes, but by the year 2000, one in 75 people in the United States will develop the dise ...
Link to itemCite
Journal ArticleSemin Surg Oncol · 1993
Over the last decade, both immunotherapy and gene therapy have emerged as exciting new modalities in the treatment of malignant melanoma. The fact that many melanoma patients mount cellular and humoral responses against their tumors, and that melanomas exp ...
Link to itemCite
Journal ArticleArch Surg · November 1992
A total of 2468 patients with recurrent melanoma were subdivided on the basis of disease-free interval: group 1 had recurrences within 1 year (n = 810), group 2 at years 1 to 3 (n = 1001), group 3 at years 3 to 5 (n = 363), group 4 at years 5 to 10 (n = 32 ...
Full textLink to itemCite
Journal ArticleCancer · October 1, 1992
BACKGROUND: Melanoma may remain clinically dormant for years, and patients may have distant metastatic disease decades after the initial diagnosis is made. Because of this potential for late recurrence, the concept of "cure" for melanoma is not particularl ...
Full textLink to itemCite
Journal ArticleLaryngoscope · August 1992
Historically, Breslow classified thin melanomas as invasive lesions less than 0.76 mm in depth with rare instances of recurrence and mortality. From 1970 to 1990, 87 patients with thin head and neck melanoma were treated at Duke Medical Center. A computer- ...
Full textLink to itemCite
Journal ArticleCancer · April 1, 1992
Tumor-infiltrating lymphocytes (TIL) were isolated from a human melanoma metastatic to the abdomen. The TIL were 99% CD3+ and 99% CD4+ and CD8-. They were dependent on interleukin-2 (IL-2) for growth, as measured in a thymidine uptake assay, and were not c ...
Full textLink to itemCite
Journal ArticleSurg Oncol · April 1992
The administration of anti-melanoma murine monoclonal antibody (MAB) 16.C8 (IgG2a) to nude mice bearing established human melanoma lung or liver metastases resulted in a significant inhibition of tumour growth. A total dose of 2 mg of affinity purified 16. ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 1992
From 1970 to 1990, 7564 patients with melanoma were seen at Duke University Cancer Center. Complete follow-up data were available in all patients. The estimated probability of a pulmonary metastasis developing 5, 10, or 20 years after initial diagnosis was ...
Link to itemCite
Journal ArticleCancer Res · January 15, 1992
We investigated the efficacy of human melanoma-specific cytotoxic T-cells (CTLs) in treating experimental human melanoma metastases in a nude mouse model of adoptive immunotherapy. Hepatic metastases were generated by the intrasplenic injection of 1.5 x 10 ...
Link to itemCite
Journal ArticleAnn Plast Surg · January 1992
Systemic therapy for metastatic malignant melanoma has been disappointing. The search for alternate therapeutic methods includes investigation of the interaction between melanoma and the human immune system. A cellular immune response to melanoma has been ...
Full textLink to itemCite
Journal ArticleAnn Plast Surg · January 1992
Specific active immunotherapy for melanoma has been administered to several thousand patients since 1972, using an irradiated whole-cell preparation. A humoral response to vaccination can be demonstrated in a large percentage of patients. This response inc ...
Full textLink to itemCite
Journal ArticleHum Antibodies Hybridomas · January 1992
Active specific immunotherapy with irradiated allogeneic melanoma cells has been shown to enhance the humoral immune response in melanoma patients. An increased titer of melanoma-binding antibodies was demonstrated in sera of immunized patients. Lymph node ...
Link to itemCite
Journal ArticleAnn Plast Surg · January 1992
Among 100 patients diagnosed with melanoma during pregnancy and followed a mean of 6.8 years, when compared with a nonpregnant female population, there was a significantly shorter disease-free interval for the pregnant group. Median disease-free intervals ...
Full textLink to itemCite
Journal ArticleAnn Plast Surg · January 1992
Twenty-four patients with primary anorectal melanoma diagnosed since 1974 have been retrospectively studied. The most common presenting symptom was rectal bleeding, typically misdiagnosed as hemorrhoids. Progressive disease most commonly presented as a lar ...
Full textLink to itemCite
Journal ArticleAnn Plast Surg · January 1992
Thin melanomas can metastasize and can be lethal. Six hundred eighty-one patients with melanomas less than 0.76 mm thick have been evaluated, and are reviewed in this study and discussed in the context of a literature review. Among those referred without m ...
Full textLink to itemCite
Journal ArticleAnn Plast Surg · January 1992
The prognostic factors for stage 1, 2 melanoma have been elucidated. Tumor thickness, ulceration of the primary melanoma, and perhaps, primary site may be used to predict the percentage of patients with regional nodal disease or systemic metastases and the ...
Full textLink to itemCite
Journal ArticleAnn Plast Surg · January 1992
Therapeutic considerations are discussed based on recurrence and survival statistics of 900 patients treated at Duke University Medical Center (Durham, NC). Approximately one-third of all patients developed recurrence. Factors affecting recurrence include ...
Full textLink to itemCite
Journal ArticleJ Cutan Pathol · December 1991
Image analysis of DNA content was performed from single nuclei of melanoma monolayer imprints made from fresh frozen tissue of 14 patients with primary malignant melanoma and 16 patients with local recurrences at the incision site and local or distant meta ...
Full textLink to itemCite
Journal ArticleArch Surg · November 1991
A search of patients seen at the Duke University Melanoma Clinic (Durham, NC) identified 79 black patients. Five- and 10-year survival was 35% and 26%, respectively. Patients presenting in the recent decade had less advanced disease, resulting in an improv ...
Full textLink to itemCite
Journal ArticleAm J Surg · November 1991
Malignant melanoma is the most common metastatic lesion of the intestine. Surgical consultation is often sought when bowel metastases become symptomatic. To determine the role of surgical intervention in such cases, a database of 6,000 melanoma patients wa ...
Full textLink to itemCite
Journal ArticleMol Biother · September 1991
Murine, antihuman melanoma cell monoclonal antibody (mAb) 16.C8 was generated by fusing the murine myeloma cell line P3X63/Ag8.653 with splenocytes from a nude mouse bearing a human melanoma xenograft, after reconstitution with splenocytes from syngeneic i ...
Link to itemCite
Journal ArticleArch Surg · April 1991
We investigated the effects of human melanoma-specific cytotoxic T lymphocytes in treating experimental human melanoma hepatic metastases in a nude mouse model of adoptive immunotherapy. Hepatic metastases were generated by intrasplenic injection of 1.5 x ...
Full textLink to itemCite
Journal ArticleJ Immunol · March 1, 1991
Autologous melanoma-specific CTL recognize a common tumor-associated Ag (TAA) in the context of HLA class I antigens. We have demonstrated that HLA-A2 can be a restricting Ag and, in T cell lines homozygous for HLA-A2, that CTL can be generated by stimulat ...
Link to itemCite
Journal ArticleSurgery · February 1991
Melanoma metastatic to the adrenal gland diagnosed before death was exceedingly rare before the development of computed tomographic (CT) scanning. The records of 28 patients with melanoma metastatic to the adrenal gland seen since 1975 were reviewed. Eight ...
Link to itemCite
Journal ArticleSemin Surg Oncol · 1991
Conventional treatment for metastatic melanoma consists of surgical resection, chemotherapy, and radiation therapy. New approaches toward treatment of this disease include the development of passive and active immunotherapeutic regimens. Malignant melanoma ...
Full textLink to itemCite
Journal ArticleCancer · December 15, 1990
A retrospective search of patients seen at the Duke Melanoma Clinic from 1970 to 1986 identified 308 clinically Stage I patients, with 4.0 to 10.0 mm cutaneous melanomas. Five-year and ten-year survival was 56% and 43%, respectively. Elective lymph node di ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · October 1990
One hundred eight-five patients with acral melanoma treated since 1972 were reviewed. These included 53 subungual lesions, 123 plantar lesions, and 9 palmar lesions. Eighty percent presented with stage I disease. Mean age was 57 years. Males outnumbered fe ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · August 1990
Recent investigations suggest that adjuvant hyperthermia enhances the response of human malignant melanoma to ionizing radiation. A study was undertaken to explore the effect of radiation and hyperthermia on the responsiveness of melanoma following active ...
Full textLink to itemCite
Journal ArticleJ Biol Response Mod · August 1990
Interactions between the cellular and humoral compartments of the human immune system are well documented. Leukoregulin (LR) is a hormone with the ability to upregulate the natural killer (NK) phenomenon by increasing target cell sensitivity to NK lymphocy ...
Link to itemCite
Journal ArticleAnn Surg · August 1990
Analysis of 7104 patients with melanoma seen at Duke University identified 168 who experienced their first recurrence 10 or more years after diagnosis, for an incidence of 2.4%. This included patients with all stages of disease. There was no sex, age, or p ...
Full textLink to itemCite
Journal ArticleAnn Surg · May 1990
Melanoma is often diagnosed in young adults, a significant proportion of whom are women of child-bearing age. The prognosis of women diagnosed with melanoma during a pregnancy continues to be debated. One hundred patients, ages 19 to 40 years, have been id ...
Full textLink to itemCite
Journal ArticleCancer Res · February 1, 1990
Autologous tumor-specific cytotoxic T-lymphocytes (CTLs), generated by repeated stimulation with autologous melanoma and expanded in interleukin 2, are major histocompatibility complex restricted. These CTLs recognize a common tumor-associated antigen in t ...
Link to itemCite
Journal ArticleCell Immunol · February 1990
Human melanoma-specific, HLA restricted, cytotoxic T-cell lines can be generated by in vitro stimulation and culturing of peripheral lymphocytes, or lymph node cells, with autologous or HLA-A region matched melanomas in the presence of a low concentration ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · February 1990
Melanoma-specific T-cells (CTLs) are specifically cytotoxic for autologous tumor, when assayed in vitro. To examine their effectiveness in vivo, we tested the ability of these human T-cells to inhibit growth of human melanoma xenografts by using a Winn ass ...
Full textLink to itemCite
Journal ArticleHead Neck · 1990
Forty-seven patients underwent pharyngoesophageal reconstruction using a free jejunal interposition graft (FJIG) at Duke University Medical Center from 1978 through 1987. There were 30 men and 17 women with ages ranging from 38 to 87 years old (mean age, 6 ...
Full textLink to itemCite
Journal ArticleSurgery · January 1990
Twenty-four patients with primary anorectal melanoma diagnosed since 1974 have been studied retrospectively. There was a predominance of women (2.4:1): Mean age was 64 years. The most common initial symptom was rectal bleeding, typically misdiagnosed as he ...
Link to itemCite
Journal ArticleAnn Surg · January 1990
In a detailed review of cystic hepatobiliary neoplasms, we identified a subset of 50 cases in which tumors were characterized by the presence of a mesenchymal cell layer interposed between an inner epithelial lining and an outer connective tissue layer. We ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 1989
Cytotoxic T lymphocytes (CTL) specific for autologous human melanoma have been generated in vitro from peripheral blood lymphocytes (PBL) of five patients with resectable stage II malignant melanoma. The PBL were cultured with 5u/ml recombinant IL-2 and we ...
Full textLink to itemCite
Journal ArticleJ Immunol · May 1, 1989
CTL lines were established in vitro by stimulating patient lymphocytes with autologous melanoma cells in the presence of IL-2. Resulting CTL lines lysed autologous melanoma and failed to lyse several allogeneic melanomas or K562. The mechanism of target ce ...
Link to itemCite
Journal ArticleSurg Gynecol Obstet · March 1989
Malignant melanoma in children and adolescents is a rare phenomenon. During a retrospective computer-aided chart review, 78 patients less than 20 years of age were identified who had the diagnosis of malignant melanoma. This accounted for 1.8 per cent of a ...
Link to itemCite
Journal ArticleJ Biol Response Mod · February 1989
Sera from melanoma patients undergoing immunization with three distinct immunogens were evaluated for development of IgG antibody specific for the melanoma tumor-associated antigens (TAAs) GD3 and 250-kd glycoprotein (high molecular weight; HMW). Of 99 pat ...
Link to itemCite
Journal ArticleCancer Immunol Immunother · 1989
The immunogenicity of the disialoganglioside, GD3, a melanoma-tumor-associated antigen, has been evaluated in non-human primates. Sera from four chimpanzees and two monkeys were evaluated for anti-GD3 antibody activity by solid-phase radioimmunoassay using ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · November 1988
The ability to redefine risk factors and to predict prognosis in patients with malignant melanoma at the time they manifest nodal metastasis can be a benefit to the patient emotionally and to the physician therapeutically. A retrospective review of 1,273 p ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · September 7, 1988
Human T-cell populations specifically cytotoxic for autologous melanoma cells have been successfully generated from lymph node cells obtained from seven consecutive patients. The lymph node cells were stimulated in vitro with autologous irradiated melanoma ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 1988
Thin melanomas can metastasize and be lethal. The purpose of this review was to identify negative risk factors in patients with melanomas less than 0.76 mm thick. Six hundred and eighty-one (681) such patients are reviewed in this study. Of those referred ...
Full textLink to itemCite
Journal ArticleCancer · July 1, 1988
The in vitro development of tumor-specific cytotoxic T-cells from draining and tumor-involved lymph nodes obtained from melanoma patients were examined. Fresh draining or tumor-involved lymph node cells (LNC) demonstrate no significant cytotoxic activity a ...
Full textLink to itemCite
Journal ArticleLaryngoscope · February 1988
Malignant melanoma of the head and neck is a potentially lethal disease and considered rare among juveniles. Treatment patterns have historically been dictated by experience with adults, however a paucity of data is available to determine the natural histo ...
Full textLink to itemCite
Journal ArticleJ Comput Assist Tomogr · 1988
A case of malignant biliary cystadenoma with CT and angiographic findings is reported. Clinical presentation, possible origin, epidemiology, and differential diagnosis of biliary cystadenoma and cystadenocarcinoma are discussed. ...
Full textLink to itemCite
Journal ArticlePancreas · 1988
Previous studies have shown that the DU-PAN-2 antigen is elevated in approximately 70% of serum samples obtained from pancreatic adenocarcinoma patients, and within the normal range (less than 400 U/ml) in 99% of normal subjects. In this study, the DU-PAN- ...
Full textLink to itemCite
Journal ArticleArch Surg · December 1987
Lymphocytes from ten patients with melanoma were specifically stimulated in vitro with autologous melanoma cells and expanded in interleukin 2. Significant lysis of autologous melanoma cells was demonstrated in T cells derived from six of these patients. T ...
Full textLink to itemCite
Journal ArticleArch Surg · December 1987
In this phase Ia/Ib trial, vaccinia melanoma oncolysate (VMO) is a virus-augmented melanoma cell membrane vaccine that has been shown to be safe and to stimulate the production of antimelanoma antibodies in high-risk melanoma patients treated in a surgical ...
Full textLink to itemCite
Journal ArticleCancer Res · December 1, 1987
A Phase I-II clinical trial of high dose single agent busulfan (16-20 mg/kg) administered over a 4-day period was undertaken. Pharmacokinetic measurements reveal that steady state total plasma busulfan levels between 2 and 10 microM were achieved by the se ...
Link to itemCite
Journal ArticleArch Surg · November 1987
The outcome of patients with stage I malignant melanoma has been well assessed in terms of prognostic factors and their effect on survival; however, little is known of the recurrence patterns of cutaneous melanoma or the survival of these patients subseque ...
Full textLink to itemCite
Journal ArticleAm J Med Sci · November 1987
A quantitative assessment of the long-term prognostic value and clinical usefulness of recall antigen reactions in patients with malignant melanoma is not available. The authors evaluated longitudinal observations of survival made in 846 patients over a 12 ...
Full textLink to itemCite
Journal ArticleArch Surg · November 1987
Twenty-two patients with inflammatory breast carcinoma received preoperative chemotherapy consisting of weekly administration of cyclophosphamide, doxorubicin hydrochloride, fluorouracil, and vincristine sulfate for six weeks. Postoperative therapy consist ...
Full textLink to itemCite
Journal ArticleArch Dermatol · June 1987
Controversy regarding the presence of estrogen receptor proteins in human melanomas persists despite extensive investigations on this subject. While apparent high-affinity binding has been observed using dextran-coated charcoal assays, several other charac ...
Link to itemCite
Journal ArticleAnn Surg · May 1987
Since January 1984, 74 patients (61 men, 13 women; age range: 43-76 years) with carcinoma of the esophagus were evaluated. Fifty-two patients had squamous cell carcinoma and 22 patients had adenocarcinoma. Sixty-three patients had preoperative chemotherapy ...
Full textLink to itemCite
Journal ArticleCancer Immunol Immunother · 1987
Melanoma high molecular weight tumor-associated antigen (TAA), having a molecular weight of 250 kilodaltons (Kd), was purified from a crude cell membrane extract through a combination of lectin affinity, immunoadsorption, and high performance liquid molecu ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · November 1986
Fine needle aspiration biopsies (FNABs) from 298 lesions in patients with suspected metastatic melanoma were studied. The results were correlated either with histopathologic diagnoses on resected lesions or with prolonged clinical follow-up. Of 165 maligna ...
Link to itemCite
Journal ArticleInvest Radiol · July 1986
Patients with melanoma have prognostic indicators that can be accurately assessed using standard histopathologic techniques. First-order lymph node disease plays a significant role in determining both the prognosis of the patient and the therapeutic benefi ...
Full textLink to itemCite
Journal ArticleJ Rheumatol · April 1986
We describe a case of isolated pectoralis swelling and tenderness, without systemic signs of infection, in a North American adult with diabetes mellitus and rheumatoid arthritis. The etiology was discovered to be pyomyositis, usually thought to be a diseas ...
Link to itemCite
Journal ArticleCancer · February 1, 1986
Vaccinia melanoma oncolysates (VMO) were tested in a Southeastern Cancer Study Group (SECSG) Phase I/II trial. Forty-eight patients with high-risk Stage I or pathologic Stage II disease were placed on study at six different dose levels and two different tr ...
Full textLink to itemCite
Journal ArticleActa Cytol · 1986
The prognostic and therapeutic decisions in cases of metastatic melanoma depend upon the morphologic documentation of metastatic disease, which may rapidly and accurately be done by fine needle aspiration (FNA) biopsy of clinically suspicious lesions. The ...
Link to itemCite
Journal ArticleTransplantation Proceedings · January 1, 1986
Analyses of infiltrates present in rejecting renal transplants have demonstrated a predominance of T-cells. Although these cells have generally had a short life span in vitro, techniques for long-term propagation of them have recently been developed. In an ...
Cite
Journal ArticleArch Otolaryngol · November 1985
Forty patients underwent pharyngoesophageal reconstruction with a free jejunal interposition graft (FJIG). Three categories of disease were treated: (1) primary upper aerodigestive tract carcinomas, (2) recurrent carcinomas, and (3) benign pharyngoesophage ...
Full textLink to itemCite
Journal ArticleAnn Surg · October 1985
DU-PAN-2 is a high molecular weight glycoprotein defined by a murine monoclonal antibody elicited to a pancreatic ductal adenocarcinoma cell line. This monoclonal antibody recognizes an oncofetal antigen present on the surface of pancreatic tumor cells. Th ...
Full textLink to itemCite
Journal ArticlePlast Reconstr Surg · September 1985
Immediate reconstruction of a breast removed for treatment of carcinoma can be accomplished without altering the cancer-ablative surgical procedure. The theoretical possibility that reconstruction might compromise the cure rate has tempered enthusiasm for ...
Full textLink to itemCite
Journal ArticleAnn Surg · April 1985
Definition of normal cell membrane antigens using immunologic techniques has permitted investigators to distinguish normal cells from malignant cells. Malignant cells express fetal antigens in concentrations different from normal mature cells. Mutant cells ...
Full textLink to itemCite
Journal ArticleCancer · March 15, 1985
Confusion exists concerning the influence of pregnancy on survival in patients with malignant melanoma. To evaluate this problem a retrospective computer-aided study was performed of women in the child-bearing years treated for Stage I cutaneous melanoma a ...
Full textLink to itemCite
Journal ArticleAnal Quant Cytol Histol · March 1985
Immunocytopathologic studies were performed on 79 fine needle aspiration biopsies (FNABs) and effusions from 13 melanomas and 57 other human neoplasms with the monoclonal antibody (MAb) D6.1 raised against a partially purified melanoma-tumor-associated ant ...
Link to itemCite
Journal ArticleSurg Gynecol Obstet · October 1984
While data concerning melanoma survival differences between the sexes as they relate to anatomic site, stage and age is scattered throughout the literature, few single studies on one large population of patients with melanoma have specifically addressed al ...
Link to itemCite
Journal ArticleProc Natl Acad Sci U S A · August 1984
A competition radioimmunoassay was developed, utilizing a murine monoclonal antibody to human pancreatic adenocarcinoma cells. Immunoblotting of a standard antigen preparation from either serum or ascites fluid after electrophoresis in 1% agarose showed th ...
Full textLink to itemCite
Journal ArticleSurgery · June 1984
Malignant melanoma is the most common malignancy to metastasize to the gastrointestinal tract. In a retrospective computer-assisted data search of over 2500 patients with melanoma registered over the past 10 years, 110 patients have been identified to have ...
Link to itemCite
Journal ArticleNihon Geka Gakkai Zasshi · February 1984
Evaluation of cellular immunity against human melanoma was performed in an in vivo model using Balb/c nude mice bearing the human melanoma. Intraperitoneal injection of 1 X 10(7) melanoma cells produced peritonitis carcinomatosa which lead to death of the ...
Link to itemCite
Journal ArticleHybridoma · 1984
An IgM monoclonal antibody, D6.1, has been obtained by fusion of P3 X 63Ag8.653 with spleen cells from congenitally athymic nu/nu mice immunized with partially purified human melanoma TAA bound to insolubilized lens culinaris lectin. The D6.1-defined antig ...
Full textLink to itemCite
Journal ArticleInvest Radiol · 1984
Malignant melanoma is an unpredictable and often virulent cutaneous malignancy. Although computed tomography is the most sensitive method for detection of intrathoracic metastases, its value in the assessment of abdominal spread has not been fully defined. ...
Full textLink to itemCite
Journal ArticleArch Otolaryngol · December 1983
A retrospective search of the Duke University Melanoma Clinic patients identified 399 cases with primary malignant melanoma located in the head and neck region. Ninety-five percent of the deaths in this series were from metastatic melanoma. Various clinica ...
Full textLink to itemCite
Journal ArticleAm Surg · December 1983
Lymphoscintigraphy using technetium-99m atimony sulfur colloid was performed in 22 patients with melanoma referred to Duke University Comprehensive Cancer Center in an attempt to identify patterns of regional lymphatic drainage. Scans from six patients rev ...
Link to itemCite
Journal ArticleAnn Surg · September 1983
One of the most controversial areas in the management of malignant melanoma concerns the efficacy of prophylactic lymph node dissection. During a retrospective computer-aided data review of over 3000 melanoma patients referred to the Duke University Cancer ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · July 1983
Recently a murine monoclonal antibody (A2B5) has been described that reacts with a membrane associated GQ ganglioside common to peptide secreting normal cells and tumors. In vitro binding data demonstrated the presence of this ganglioside on neurons, adren ...
Full textLink to itemCite
Journal ArticleAm J Pathol · July 1983
Because of the technical difficulties encountered with human islet cell transplantation, alternatives toward supplying the juvenile diabetic with an endogenous insulin source are sought. With the use of a streptozotocin-induced diabetic rat model, it was f ...
Link to itemCite
Journal ArticleAJR Am J Roentgenol · July 1983
A prospective comparison of chest radiography, conventional tomography, and computed tomography (CT) in the detection or confirmation of solitary pulmonary nodules was made in 42 patients with high propensity for pulmonary metastases due to advanced local ...
Full textLink to itemCite
Journal ArticleLaryngoscope · June 1983
Utilization of a posterior neck dissection in the treatment of nine patients with malignant melanoma of the posterior scalp is presented. Seven of nine patients presented with metastatic disease present in the posterior neck after initial treatment elsewhe ...
Full textLink to itemCite
Journal ArticleRes Commun Chem Pathol Pharmacol · May 1983
We compared the properties of monoamine oxidase (MAO) in hamster islets and insulinomas. The tryptamine concentration at which the monoamine oxidase velocity was half maximal (Km) was higher in islets than insulinomas; the maximal velocity (Vmax) of monoam ...
Link to itemCite
Journal ArticleSurg Gynecol Obstet · March 1983
Patients who are diagnosed initially as having metastatic melanoma with no known cutaneous, mucosal or ocular primary are a perplexing clinical problem. In the Duke University Melanoma Clinic, 124 patients have been identified as meeting the criteria of an ...
Link to itemCite
Journal ArticleSurgery · February 1983
Cyclosporin A (CyA), an investigational immunosuppressive drug, was tested for its ability as a single agent to prevent rejection and maintain function of islet cell tumors transplanted across a major histocompatibility barrier. Lewis rats have previously ...
Link to itemCite
Journal ArticleHybridoma · 1983
Monoclonal antibody A2B5 reacts with the cell surface of a series of amine precursor uptake decarboxylation (APUD) cells and their tumors in many vertebrate species including chicken, rat, mouse, and man. We have studied the in vivo and in vitro binding of ...
Full textLink to itemCite
Journal ArticleJAMA · October 15, 1982
Malignant melanoma, a type of cancer that accounts for 1% to 3% of all malignant neoplasms in 20 times more frequent in the American white than black population. During a computer-aided retrospective chart review of more than 2,500 patients with melanoma b ...
Link to itemCite
Journal ArticleAm J Pathol · June 1982
Differences in immunoglobulin localization (IgG, IgM, IgA) in benign versus malignant lesions of the human mammary gland have been previously demonstrated. The present investigation was undertaken to evaluate the influence of menstrual cycling on these imm ...
Link to itemCite
Journal ArticleAnn Plast Surg · January 1982
In 62 patients in whom modified radical mastectomy was accompanied by immediate breast reconstruction, the operative and pathologic findings are compared to the clinical results. Immediate reconstruction following modified radical mastectomy appears to off ...
Full textLink to itemCite
Journal ArticleHybridoma · 1982
Selected murine monoclonal antimelanoma antibodies have been extensively evaluated using multiple radioimmunoassay methods, immunoprecipitation and immunohistochemistry. Use of this approach has permitted more complete definition of the specificity of thes ...
Full textLink to itemCite
Journal ArticleAnn Surg · November 1981
Specific in vivo localization of antibodies reactive with human melanoma cell membrane tumor associated antigens (TAA) has been attempted using congenitally athymic nude mice bearing subcutaneous human melanoma tumor xenografts as the experimental model. I ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · October 1981
Lymphoscintigrams were performed using technetium-99m antimony sulfur colloid in 21 patients with cutaneous malignant melanoma. Scintigraphic results were concordant with clinical prediction of lymph drainage in six of 11 patients with trunk melanoma, in f ...
Full textLink to itemCite
Journal ArticleSchweiz Med Wochenschr · September 5, 1981
Since Morton demonstrated in 1968 that malignant melanoma is antigenic, many immunologists have taken an interest in this disease. A basis for specific active immunotherapy has been worked out at Duke University Medical Center, Durham, N.C. (USA). A female ...
Link to itemCite
Journal ArticleAJR Am J Roentgenol · August 1981
Early detection of metastatic melanoma has become more important as newer and more effective therapeutic regimens are used. Between 1970 and 1980, 1,600 patients were treated at one institution for malignant melanoma. Of these, 260 (16.3%) developed thorac ...
Full textLink to itemCite
Journal ArticleCancer · July 1, 1981
Using direct imunofluorescence, lesions from 266 human breast specimens were studied for the presence of IgA, IgM, or IgG localization. The lesions included benign elements from 66 subcutaneous mastectomy specimens in which the absence of simultaneous brea ...
Full textLink to itemCite
Journal ArticleAnn Surg · May 1981
Fifty patients undergoing immediate reconstruction of the breast following modified radical mastectomy for carcinoma were characterized by their clinical findings and the pathologic features of their tumors. Evidence of nipple--areolar involvement by tumor ...
Full textLink to itemCite
Journal ArticleJ Pediatr Surg · February 1981
Because high blood pressure in children is rare and most of these patients are asymptomatic, many are overlooked until they present with a hypertensive crisis or irreparable damage. Most children with renal artery stenosis are asymptomatic and the hyperten ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · 1981
Evaluation of cell mediated immunity against human melanoma target cells was performed in an in vivo model using human tumor xenografts growing in Balb/c athymic mice. Intraperitoneal inoculation of 1 x 10(7) human melanoma cells produced carcinomatosis wh ...
Full textLink to itemCite
Journal ArticleNeurosurgery · January 1981
In a series of 1341 patients with histologically proven malignant melanoma seen at Duke University Medical Center from 1968 to 1978, 107 patients developed central nervous system (CNS) metastases. These patients were evaluated on the basis of which factors ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · 1981
Intraperitoneal injections of 2 X 10(7) SH-Me cells (human metastatic melanoma cells)( to 20 Balb/c nu/nu mice (Group A) and 1 X 10(7) cells to 20 mice (Group B) were performed. All animals were studied clinicopathologically. Five animals in Group A were s ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · 1981
Mouse hepatitis virus (MHV) infection was found in 15 of 40 athymic mice (Balb/c nu/nu) used in an experimental model designed to study the effect of cell mediated immunity on target human melanoma cells growing in the peritoneal cavity. Most non-MHV-infec ...
Full textLink to itemCite
Journal ArticleCancer · December 1, 1980
Treatment of 91 consecutive patients having metastatic, Stage IV melanoma who had not received any previous chemotherapy was begun between January 1977 and April 1978. The therapy included bleomycin (B) at 7.5 units subcutaneously in the first course and 1 ...
Full textLink to itemCite
Journal ArticleCancer · September 15, 1980
Melanomas from 20 patients were evaluated for estrogen and progesterone receptors. No restriction as to patient's age, sex, race, or menstrual status was made. Fifteen of the tumors were melanin producing. Of the 20 tumors examined, seven contained more th ...
Full textLink to itemCite
Journal ArticleTransplantation · July 1980
We investigated the genetics of transplanting a NEDH rat insulinoma in various donor-recipient combinations. The insulinoma survived indefinitely when it was transplanted in the NEDH strain. Mean survival times of 8.6 +/- 1.2 and 3.3 +/- 1.0 days were reco ...
Full textLink to itemCite
Journal ArticleNeurosurgery · May 1980
A 37-year-old white woman presented with progressive visual loss in the right eye. The diagnostic evaluation suggested a tumor in the suprasellar area. At operation an isolated melanoma was found just superior to the sella turcica. No evidence of other int ...
Full textLink to itemCite
Journal ArticleSurg Gynecol Obstet · April 1980
In a prospective analysis of 291 specimens taken at mastectomy for carcinoma, 48 contained tumor in the nipple-areola complex. The characteristics of greater tumor size, higher frequency of lymph node involvement, midbreast tumor location and multifocality ...
Link to itemCite
Journal ArticleJ Surg Oncol · 1980
Xenoantiserum, alloantiserum, and autoantiserum prepared against human melanoma cells from cell lines maintained in tissue culture were evaluated by indirect immunofluorescence (ind IF) for their content of antibodies reactive with melanoma cell membrane t ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 1980
Syrian hamsters were rendered diabetic with intraperitoneal streptozotocin and were maintained in the diabetic state for a minimum of 14 days. A hamster islet cell tumor was transplanted subcutaneously with a prompt return of water intake (38 +/- 9.1 ml/da ...
Full textLink to itemCite
Journal ArticleAnn Surg · 1980
The postoperative function of "free" jejunal autotransplants for replacement of the pharyngoesophagus after palliative resection was evaluated in nine patients using clinical assessment, cinefluoroscopy, manometry, and electrical studies. After an initial ...
Full textLink to itemCite
Journal ArticleAnn Surg · November 1979
Six cases of cystosarcoma phylloides were evaluated by ultrastructure and steroid receptor analysis. Electron microscopy of the lesions supported previous reports of a heterogeneous tumor consisting of pleomorphic mesenchyme and normal or proliferative epi ...
Full textLink to itemCite
Journal ArticleAnn Surg · October 1979
A computer analysis of post renal transplantation gastrointestinal problems was performed to identify important associated clinical factors. Thirty-seven per cent of all transplant recipients developed one or more significant problems. Hemorrhage, nondiver ...
Full textLink to itemCite
Journal ArticleDiabetologia · October 1979
Hamster and rat insulinomas were assayed for norepinephrine, dopamine and serotonin concentration and for monoamine oxidase and catechol-o-ethyltransferase (COMT) activity. The concentration of norepinephrine (mean 0.55 mumol/kg, range less than 0.20 to 2. ...
Full textLink to itemCite
Journal ArticleJ Surg Oncol · 1979
Conflicts amongst reports concerning the efficacy of both nonspecific and specific attempts at immunotherapy may be ascribed to different animal models utilizing tumors of different immunogenicity. We have selected the B16 mouse melanoma model as the examp ...
Full textLink to itemCite
Journal ArticleGastrointestinal Radiology · October 1, 1978
Twenty-one patients with documented secondary small bowel involvement by malignant melanoma are reviewed. Roentgen mainfestations are discussed and illustrated. A vigorous diagnostic approach emphasizing enteroclysis is described. Clinical awareness and ag ...
Cite
Journal ArticleGastrointest Radiol · October 1, 1978
Twenty-one patients with documented secondary small bowel involvement by malignant melanoma are reviewed. Roentgen mainfestations are discussed and illustrated. A vigorous diagnostic approach emphasizing enteroclysis is described. Clinical awareness and ag ...
Full textLink to itemCite
Journal ArticleTransplantation · September 1978
Survival of 436 ABO-compatible skin grafts exchanged in 97 Caucasian families was prolonged if donor and recipient were genotypically, as compared with phenotypically, HLA identical. Among skin grafts between haploidentical family members, a mismatch at th ...
Full textLink to itemCite
Journal ArticleJ Bone Joint Surg Am · July 1978
Sixteen hundred and seventy-seven melanoma patients were treated at Duke University Medical Center from 1956 to 1976. Osseous metastases were more common than previously reported and occurred in 116 patients (6.9 per cent), most often in the axial skeleton ...
Link to itemCite
Journal ArticleAnn Surg · July 1978
This report defines the incidence of variations in the renal vascular pedicle in a group of patients with normal renal function as determined by standard laboratory criteria. The study group consisted of 166 patients undergoing renal arteriography as poten ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · July 1978
Human melanoma cell membrane tumor-associated antigens (TAA's) were solubilized in an active form by pronase digestion of either a fresh melanoma or cells from a melanoma cell line maintained in tissue culture. Upon elution from Sephadex G-200 column, TAA' ...
Full textLink to itemCite
Journal ArticleAnn Surg · July 1978
Cloacogenic carcinoma is a rare tumor of the anorectal region originating from a persistant remnant of the cloacal membrane of the embryo. The tumor accounts for 2-3% of anorectal carcinomas and occurs more than twice as often in women. Most tumors present ...
Full textLink to itemCite
Journal ArticleCancer Res · May 1978
Peripheral blood lymphocytes from 15 patients with hypernephroma were stimulated with partially purified tumor plasma membranes to incorporate [3H]thymidine. Kidney tumor and normal kidney membranes were adjusted to antigenic equivalence as determined by t ...
Link to itemCite
Journal ArticleArch Pathol Lab Med · April 1978
The clinical and pathological findings of two patients with ectopic gastric mucosa within the gallbladder are studied and compared with the findings recorded in the literature. A contrast between incidental and symptomatic ectopia was noted in these cases. ...
Link to itemCite
Journal ArticleAm J Clin Pathol · June 1977
Three cases of metastatic malignant lesions are presented. By conventional pathologic examination these lesions were diagnosed as undifferentiated carcinomas. They were studied using a chimpanzee antiserum specific for human melanoma-associated antigens. I ...
Full textLink to itemCite
Journal ArticleSurgery · March 1977
During the past decade 45 living related renal allografts have been performed between siblings genotypically identical for HLA. In each case all available family members were serotyped and haplotype analysis was performed. Immunosuppressive therapy consist ...
Link to itemCite
Journal ArticleJ Natl Cancer Inst · February 1977
A chimpanzee anti-human melanoma antiserum was used to study the enzymatic susceptibility and spontaneous release into tissue culture medium of human melanoma tumor-associated antigens (TAA). Limited proteolytic digestion of melanoma cells with trypsin or ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · January 1977
The chemotactic responsiveness of peripheral blood monocytes was studied before and after immunotherapy was administered to 56 patients with melanoma. Abnormal chemotaxis was found in 36 patients (64%) prior to treatment; this abnormality correlated with s ...
Full textLink to itemCite
Journal ArticleMonogr Allergy · 1977
Cutaneous responses to tuberculin and control antigens were measured in 24 HLA-B7 and 39 non-B7 patients before and 5-44 (average 10.5) weeks after BCG immunotherapy for malignant melanoma. Delayed tuberculin hypersensitivity increased after immunotherapy ...
Link to itemCite
Journal ArticleJAMA · August 30, 1976
A young woman with progressive systemic sclerosis (PSS) and renal failure who received a renal transplant from her mother suffered accelerated loss of allograft function in the absence of hyperacute rejection or severe hypertension. A biopsy specimen and p ...
Link to itemCite
Journal ArticleSurgery · March 1976
Fifty-nine recipients received renal allografts from an HL-A haploidentical family member. Immunogenicity of the incompatible haplotype was measured by skin grafts exchanged within each family when possible, and renal allograft recipients were assigned pro ...
Link to itemCite
Journal ArticleJ Immunol Methods · 1976
High-titered antisera against human melanoma- and leukemia-associated antigens have been produced in non-human primates. The data from this and from other studies suggest that this model may prove a valuable source of highly specific antisera against a var ...
Full textLink to itemCite
Journal ArticleAm J Roentgenol Radium Ther Nucl Med · November 1975
During the decade, February, 1965, through February, 1975, 248 patients underwent renal transplantation at the Duke Medical Center. One hundred twenty-five were living related recipients, while 123 were cadaveric recipients. Eleven patients developed ileoc ...
Full textLink to itemCite
Journal ArticleAnn Surg · November 1975
A retrospective analysis of 193 renal transplant recipients yielded 15 patients who developed pulmonary mycosis posttransplantation and one case in which mycotic lung infection existed at the time of transplant surgery. Agent responsible for infection incl ...
Full textLink to itemCite
Journal ArticleCancer Res · August 1975
An antiserum to human melanoma has been produced in a chimpanzee by hyperimmunization with melanoma cells from a single donor. After absorption with the peripheral blood lymphocytes of the tumor donor, this antiserum is specifically cytotoxic to melanoma c ...
Link to itemCite
Journal ArticleAm J Med · August 1975
Described are the clinical course and renal morphologic findings in a patient with membranoproliferative glomerulonephritis. intially, the patient had a pure form of membranoproliferative glomerulonephritis but after a 3 year course, it became crescentic. ...
Full textLink to itemCite
Journal ArticleFed Proc · July 1975
The rationale of our approach to the detection and characterization of human leukemia and melanoma associated membrane antigens is to take advantage of the unique immunological recognition perspective of simians to huamn antigens. There are enough antigeni ...
Link to itemCite
Journal ArticleCancer · March 1975
Two forms of therapy employed for treatment of patients with recurrent melanoma limited to the extremity, and carried out during different intervals of time, are presented. Perfusion of the involved extremity with phenylalanine mustard has resulted in a 5- ...
Full textLink to itemCite
Journal ArticlePlast Reconstr Surg · March 1975
An attempt was made to produce tumor immunity in 193 patients who had melanoma, 160 of whom had metastases and 33 of whom did not. Four stages of treatment are outlined. The patients whose disease was confined to the skin, subcutaneous tissues, and lymph n ...
Link to itemCite
Journal ArticleEXCERPTA MEDICA, ICS NO. 354 · 1975
Perfusion chemotherapy with Phenylalanine mustard was employed for treatment of patients with recurrent melanoma limited to the extremity, and has resulted in a 5 yr survival rate of 28% in 43 patients. The side effects of this form of treatment have been ...
Cite
Journal ArticleBEHRING INST.MITT. · January 1, 1975
BCG immunization in 193 patients proved successful for the stimulation of delayed cutaneous hypersensitivity to PPD. The data tends to refute the hypothesis that BCG immunization brings about a general augmentation of delayed cutaneous hypersensitivity. Fu ...
Cite
Book · January 1, 1975
Perfusion chemotherapy with Phenylalanine mustard was employed for treatment of patients with recurrent melanoma limited to the extremity, and has resulted in a 5 yr survival rate of 28% in 43 patients. The side effects of this form of treatment have been ...
Cite
Journal ArticleBOL.ASOC.MED.P.R. · January 1, 1974
The results in 120 patients with melanoma that the authors studied and treated by immunotherapy are described. Serum immunoglobulin levels in patients with malignant melanoma revealed normal IgA and IgG levels and only infrequent IgM values were below the ...
Cite
Journal ArticleTransplantation · January 1, 1973
The members of family Sch were studied by three different parameters: HL-A typing, mixed leukocyte reaction (MLR), and skin grafting. There were two HL-A-identical, mixed leukocyte reaction-identical siblings (MLR-S); two HL-A-identical, MLR-S- different s ...
Full textCite
Journal ArticleJ Clin Invest · December 1972
16 patients underwent renal transplantation from a sibling donor who was prospectively determined to be ABO compatible and HL-A identical with the recipient. Unidirectional mixed leukocyte reactions were performed; in each instance, lymphocyte stimulation ...
Full textLink to itemCite
Journal ArticleJ Exp Med · March 1, 1971
The immunogenicity of the haplotypes in 30 families was measured by survival of skin grafts between selected paired family members. These families were genotyped for HL-A using 57 selected cytotoxic alloantisera defining HL-A 1-12 as well as other nondefin ...
Full textLink to itemCite
Journal ArticleTransplantation · January 1, 1967
Ten antisera from multiparous women or immunized volunteers containing isoantibodies to human leukocyte antigens were fractionated on Biogel P-300 polyacrylamide chromatographic columns. The fractions were tested by lymphocyte cytotoxicity and leukocyte ag ...
Full textCite